Table 1

Baseline characteristics of participants, additionally split by receipt of domiciliary care (DC) during the study period

VariableLevelAll participants (n=140 987)Participants with DC package
DC package initiated at any time (n=2041, 1.4%)Hospital-associated DC package (n=693, 0.5%)
SexFemale71 445 (50.7)1255 (61.5)442 (63.8)
Male69 542 (49.3)786 (38.5)251 (36.2)
Age at entry19–2928 344 (20.1)23 (1.1)<10 (<1.4)
30–3934 161 (24.2)40 (2.0)<10 (<1.4)
40–4929 447 (20.9)63 (3.1)11 (1.6)
50–5922 876 (16.2)179 (8.8)45 (6.5)
60–6913 048 (9.3)301 (14.7)107 (15.4)
70–797849 (5.6)504 (24.7)187 (27.0)
80+5262 (3.7)931 (45.6)336 (48.5)
Median (IQR)42.6 (32.1–55.5)78.6 (67.6–85.6)79.6 (70.2–85.9)
ComorbiditiesBlindness1466 (1.0)114 (5.6)32 (4.6)
Cancer2992 (2.1)233 (11.4)95 (13.7)
CHD4649 (3.3)422 (20.7)162 (23.4)
Kidney2555 (1.8)320 (15.7)118 (17.0)
Liver1694 (1.2)33 (1.6)11 (1.6)
COPD4319 (3.1)370 (18.1)142 (20.5)
Dementia1246 (0.9)272 (13.3)84 (12.1)
Depression13 189 (9.4)481 (23.6)148 (21.4)
Diabetes14 413 (10.2)632 (31.0)219 (31.6)
Heart failure1358 (1.0)200 (9.8)88 (12.7)
Learning disabilities754 (0.5)24 (1.2)<10 (<2)
Parkinson’s disease258 (0.2)48 (2.4)14 (2.0)
PVD795 (0.6)82 (4.0)30 (4.3)
Stroke2503 (1.8)274 (13.4)102 (14.7)
  • Data are n (%) or median (IQR). Small groups were censored.

  • CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; DC, domiciliary care; PVD, peripheral vascular disease.